[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@OzmosiHealth Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1055982930.png) @OzmosiHealth Ozmosi

Ozmosi posts on X about more info, gilead sciences, $gild, $incy the most. They currently have XXXXX followers and 2451 posts still getting attention that total XXXXX engagements in the last XX hours.

### Engagements: XXXXX [#](/creator/twitter::1055982930/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1055982930/c:line/m:interactions.svg)

- X Week XXXXXX +27%
- X Month XXXXXXX +7.40%
- X Months XXXXXXX +1.30%
- X Year XXXXXXXXX +55%

### Mentions: XX [#](/creator/twitter::1055982930/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1055982930/c:line/m:posts_active.svg)

- X Week XXX +32%
- X Month XXX -XXXX%
- X Months XXXXX -XX%
- X Year XXXXX +29%

### Followers: XXXXX [#](/creator/twitter::1055982930/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1055982930/c:line/m:followers.svg)

- X Week XXXXX +1.30%
- X Month XXXXX +3.10%
- X Months XXXXX +27%
- X Year XXXXX +40%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::1055982930/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1055982930/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1055982930/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXX% [cryptocurrencies](/list/cryptocurrencies)  XXXX% [finance](/list/finance)  XXXX% [countries](/list/countries)  XXXX% [currencies](/list/currencies)  XXXX% [automotive brands](/list/automotive-brands)  XXXX% [technology brands](/list/technology-brands)  XXXX% [travel destinations](/list/travel-destinations)  XXXX%

**Social topic influence**
[more info](/topic/more-info) #501, [gilead sciences](/topic/gilead-sciences) 0.24%, [$gild](/topic/$gild) 0.24%, [$incy](/topic/$incy) 0.2%, [iii](/topic/iii) #1682, [breast cancer](/topic/breast-cancer) #2058, [$bmy](/topic/$bmy) 0.16%, [$cytk](/topic/$cytk) #15, [$imab](/topic/$imab) #13, [$mrk](/topic/$mrk) #56

**Top accounts mentioned or mentioned by**
[@salmanfirat2](/creator/undefined) [@grok](/creator/undefined) [@john06746191](/creator/undefined) [@stewdomer](/creator/undefined) [@dwill3000](/creator/undefined) [@chrismangum14](/creator/undefined) [@nicolem52807658](/creator/undefined) [@mitchellreed09](/creator/undefined) [@gustavocapo1978](/creator/undefined) [@paulmarganski](/creator/undefined) [@jamestheright1](/creator/undefined) [@towiu2](/creator/undefined) [@lookingatthis2](/creator/undefined) [@christo68098001](/creator/undefined)

**Top assets mentioned**
[Gilead Sciences, Inc. (GILD)](/topic/gilead-sciences) [Incyte Corporation (INCY)](/topic/$incy) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Cytokinetics Inc. (CYTK)](/topic/$cytk) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Bitcoin Incognito (XBI)](/topic/$xbi) [Pfizer, Inc. (PFE)](/topic/$pfe) [AstraZeneca PLC (AZN)](/topic/$azn) [Agios Pharmaceuticals, Inc. (AGIO)](/topic/$agio) [Moderna Inc (MRNA)](/topic/$mrna) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Eli Lilly and Company (LLY)](/topic/$lly) [Sanofi (SNY)](/topic/sanofi) [Synthetify (SNY)](/topic/$sny) [Neurocrine Biosciences, Inc. (NBIX)](/topic/$nbix) [Insmed, Inc. (INSM)](/topic/$insm) [AbbVie Inc (ABBV)](/topic/$abbv) [Summit Therapeutics Inc. Common Stock (SMMT)](/topic/$smmt) [Johnson & Johnson (JNJ)](/topic/$jnj) [Sonnet BioTherapeutics Holdings, Inc. Common Stock (SONN)](/topic/$sonn) [Biohaven Pharmaceutical Holding Company Ltd. (BHVN)](/topic/$bhvn) [Roivant Sciences Ltd. Common Shares (ROIV)](/topic/$roiv) [Parallax (PLX)](/topic/$plx) [Praxis Precision Medicines, Inc. Common Stock (PRAX)](/topic/$prax) [AB (prev. Newton) (AB)](/topic/$ab) [Viatris Inc (VTRS)](/topic/$vtrs) [Revolution Medicines, Inc. Common Stock (RVMD)](/topic/$rvmd) [Acadia Pharmaceuticals Inc. (ACAD)](/topic/$acad) [BOLT Token (BOLT)](/topic/$bolt) [BioMarin Pharmaceutical, Inc. (BMRN)](/topic/$bmrn) [Orange Swan Event (OSE)](/topic/$ose) [Chains of War (MIRA)](/topic/$mira)
### Top Social Posts [#](/creator/twitter::1055982930/posts)
---
Top posts by engagements in the last XX hours

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $MRNA Moderna will present Phase X Melanoma Data for mRNA-4359 (Relaxin Analogue - Nucleic Acid) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1978781067776770282) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T11:12Z 2802 followers, XXX engagements


"AstraZeneca expands its AI discovery pact with Immunaideals worth up to $85M to extend AI-based work beyond oncology"  
[X Link](https://x.com/OzmosiHealth/status/1979177250705592395) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:26Z 2802 followers, XX engagements


"$GILD Gilead Sciences announced they will present Phase X Triple Negative Breast Cancer results on 2025-10-19 for Sacituzumab govitecan More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216515494129718) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:49Z 2791 followers, XXX engagements


"$SONN -XXXX% today as Evaluation of SON-1010 Using a Patient-Derived Tumoroid Platform to Support an Ongoing Phase X Study in Patients with Sarcoma More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978597906501284108) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-15T23:04Z 2802 followers, XXX engagements


"$BMY Bristol-Myers Squibb announced they will present Phase X Ovarian Cancer results on 2025-10-19 for Izalontamab brengitecan More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216484070379767) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:48Z 2791 followers, XXX engagements


"$INCY Incyte announced they will present Phase X Hidradenitis Suppurativa results on 2025-09-17 for Povorcitinib More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1966235516308779295) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-09-11T20:20Z 2799 followers, XXX engagements


"$CYTK FDA extended PDUFA action date for aficamten's NDA from Sep XX 2025 to Dec XX 2025 due to REMS review. More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1975291055072227493) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-06T20:04Z 2799 followers, XXX engagements


"$CADL Candel Therapeutics presented P1 Glioblastoma results on 2025-10-14 for CAN-3110 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978597983886184772) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-15T23:04Z 2802 followers, XXX engagements


"$IRON -XXXX% today as Disc Medicine Announces Receipt of FDA Commissioner's National Priority Voucher (CNPV) for Bitopertin in Erythropoietic Protoporphyria (EPP) More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982881805381855) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2799 followers, XXX engagements


"$4568 as DATROWAY Plus Rilvegostomig Showed Promising Tumor Responses in Patients with Metastatic Urothelial Cancer in TROPION-PanTumor03 Phase X Trial More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979254182574997966) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T18:32Z 2802 followers, XXX engagements


"Daily $XBI Recap $BHVN +8% $ROIV +7% $XNCR +7% $VCEL -X% $CGEM -X% $SRPT -5%"  
[X Link](https://x.com/OzmosiHealth/status/1968504279926178135) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-09-18T02:36Z 2800 followers, XXX engagements


"$TSHA -XXXX% today as Taysha Gene Therapies Regains Full Rights to Lead TSHA-102 Program in Clinical Evaluation for the Treatment of Rett Syndrome More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982873320292815) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2800 followers, XXX engagements


"$CGEN Compugen announced they will present Phase X Ovarian Cancer results on 2025-10-18 for COM-701 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216499065036988) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:49Z 2790 followers, XXX engagements


"$JAGX -XXXX% today as Jaguar Health Completes Meeting with FDA for Advice on Development Pathways to Advance Ongoing Crofelemer Trial for Potential Approval for Treatment of Pediatric Indication Microvillus Inclusion Disease (MVID) More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1975196169950105974) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-06T13:47Z 2789 followers, XXX engagements


"$ARTL Artelo Biosciences presented P1 Healthy Volunteers results on 2025-10-16 for ART26.12 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982928718659885) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2798 followers, XXX engagements


"$LLY +0.30% today as Lilly's oral GLP-1 orforglipron demonstrated superior glycemic control in two successful Phase X trials reconfirming its potential as a foundational treatment in type X diabetes More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978458207954628757) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-15T13:49Z 2792 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $INCY Incyte will present Phase X Oncology Solid Tumor Unspecified Data for INCA-33890 (PD-1 InhibitorTGFBR2 Inhibitor - Bispecific Antibody) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1978781064199041326) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T11:12Z 2802 followers, XXX engagements


"$PLX -XXXXX% today as Chiesi Global Rare Diseases and Protalix Biotherapeutics Acknowledge CHMP Negative Opinion on Every Four Week Dosing Regimen of Elfabrio (pegunigalsidase alfa) in the EU More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183761796333833) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2802 followers, XXX engagements


"$PHAR +8.16% today as Pharming Group announces U.S. FDA acceptance and Priority Review of supplemental New Drug Application for leniolisib in children with APDS aged X to XX years More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1973383126484213950) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-01T13:42Z 2802 followers, XXX engagements


"$NVCT +1.24% today as Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978820986418958532) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T13:51Z 2802 followers, XXX engagements


"$OMER -XXXXX% today as Omeros Announces Publication Highlighting Survival Benefits in TA-TMA Patients Treated with Narsoplimab Versus a Well-Matched External Control Group More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978820994841071676) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T13:51Z 2802 followers, XXX engagements


"$PFE +0.64% today as ViiV Healthcare announces 96-week data reaffirming Dovato is as effective as Biktarvy in maintaining virological suppression of HIV-1 with significantly less weight gain More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183776849596644) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2802 followers, XXX engagements


"$GILD Gilead Sciences presented P2 HIV Infections results on 2025-10-15 for Lenacapavir More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982936855584910) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2794 followers, XXX engagements


"$RNTX -XXXX% today as Rein Therapeutics Receives European Regulatory Approval to Initiate Phase X Trial of LTI-03 in Idiopathic Pulmonary Fibrosis More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1976281340887585179) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-09T13:39Z 2800 followers, XXX engagements


"$SPRO Spero announced they will present P3 Urinary Tract InfectionsNephritisPyelonephritis results on 2025-10-20 for Tebipenem pivoxil More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978597973127782667) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-15T23:04Z 2802 followers, XXX engagements


"$RHHBY +0.65% today as Genentech Expands Xofluza Access and Affordability for Upcoming Flu Season With Direct-to-Patient Launch More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982866395570330) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2800 followers, XX engagements


"$RPTX Repare Therapeutics announced they will present Phase X Oncology Solid Tumor Unspecified results on 2025-10-25 for RP-1664 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216532002968054) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:49Z 2800 followers, XXX engagements


"$BMY Bristol-Myers Squibb announced they will present Phase X Nasopharyngeal Cancer results on 2025-10-19 for Izalontamab brengitecan More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216491569852477) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:48Z 2791 followers, XXX engagements


"$LLY -XXXX% today as Lilly's Verzenio (abemaciclib) prolonged survival in HR+ HER2- high-risk early breast cancer with two years of treatment More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183739218305424) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2802 followers, XXX engagements


"$CDTX Cidara announced they will present Phase X Influenza Human results on 2025-10-20 for CD-388 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216495290220856) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:49Z 2789 followers, XXX engagements


"Lillys oral GLP-1 orforglipron outperformed Novos Rybelsus in Phase III on glucose control and weight loss when paired with AstraZenecas Farxiga"  
[X Link](https://x.com/OzmosiHealth/status/1978515357959586038) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-15T17:36Z 2800 followers, XXX engagements


"$GMAB -XXXX% today as Genmab Announces Net Sales of DARZALEX (daratumumab) for Third Quarter of 2025 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978115140588314652) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T15:06Z 2801 followers, XXX engagements


"$PRAX +203.36% today as Praxis Precision Medicines Announces Positive Topline Results from Two Pivotal Phase X Studies of Ulixacaltamide HCl in the Essential3 Program for Essential Tremor More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978821020107596075) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T13:51Z 2802 followers, XXX engagements


"$BMY Bristol-Myers Squibb announced they will present Phase X Colorectal Cancer results on 2025-10-20 for Nivolumab More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216488180883473) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:48Z 2791 followers, XXX engagements


"$AB +0.81% today as AB Science will hold a virtual conference on Thursday October XX 2025 from 2pm to 3pm CET to provide an update on the Phase X study with AB8939 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978115133063807054) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T15:06Z 2791 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $MRNA Moderna will present Phase X Bladder CancerMuscle Cancer Data for Intismeran autogene (Vaccine - Nucleic Acid) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1978781068372377668) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T11:12Z 2802 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $AZN AstraZeneca will present Phase X Breast Cancer Data for Trastuzumab deruxtecan (ERBB2 InhibitorTOP2 Inhibitor - Antibody Drug Conjugate) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1979143454308602004) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T11:12Z 2802 followers, XXX engagements


"$ZLAB Zai Lab announced they will present Phase X Small Cell Lung Cancer results on 2025-10-24 for Zocilurtatug pelitecan More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216544233455729) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:49Z 2800 followers, XXX engagements


"$VTRS +0.70% today as Viatris Completes Acquisition of Aculys Pharma Including Exclusive Rights to Pitolisant in Japan and to Spydia in Japan and Certain Other Markets in the Asia-Pacific Region More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978597902680277123) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-15T23:04Z 2802 followers, XXX engagements


"$KZR -XXXX% today as Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis and Plans to Explore Strategic Alternatives More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982862066946545) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2799 followers, XXX engagements


"$CRVS -XXXX% today as Corvus Pharmaceuticals Announces Presentation of Interim Data from the Phase 1b/2 Clinical Trial of Ciforadenant for Patients with Metastatic Renal Cell Cancer at the European Society for Medical Oncology (ESMO) Congress 2025 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979254178993066188) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T18:32Z 2802 followers, XXX engagements


"$AGIO +5.11% today as Agios' PYRUKYND (mitapivat) Receives Positive CHMP Opinion for Adults with Thalassemia More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183754150039735) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2802 followers, XXX engagements


"$CYTK PDUFA Summary: Cytokinetics misled investors about FDA approval timeline for Aficamten leading to stock price inflation and losses. More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216561786691598) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:49Z 2800 followers, XXX engagements


"$SNY +1.13% today as Press Release: Sanofi provides update on regulatory review in the EU for Rezurock to treat chronic graft-vs-host disease More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183773276156251) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2802 followers, XXX engagements


"$APRE +4.03% today as Aprea Therapeutics Establishes Recommended Phase X Dose (RP2D) for ATRN-119 Considering Combination Therapies More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978458183845773536) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-15T13:49Z 2792 followers, XXX engagements


"$RVMD +0.22% today as Revolution Medicines Awarded Voucher for Daraxonrasib (RMC-6236) Under FDA Commissioner's National Priority Voucher Pilot Program More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982885718663245) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2800 followers, XXX engagements


"$CADL -XXXX% today as Candel Therapeutics Announces Positive Interim Data After Repeated Administration of CAN-3110 in Recurrent Glioblastoma and Announces Publication in Science Translational Medicine More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978115185156960616) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T15:06Z 2800 followers, XXX engagements


"$ENTX +1.88% today as Entera Bio to Present New Clinical Data from Phase X Trial of EB613 at the 2025 North American Menopause Society (NAMS) Annual Meeting More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978821024339644702) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T13:51Z 2802 followers, XXX engagements


"$NBIX Neurocrine presented Phase X Huntington Disease results on 2025-10-06 for Valbenazine More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1975742106305012079) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-08T01:56Z 2791 followers, XXX engagements


"$GILD Gilead Sciences announced they will present Phase X Esophageal CancerGastrointestinal Cancer results on 2025-10-18 for Zimberelimab More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216511501160861) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:49Z 2789 followers, XXX engagements


"$ARGX argenx announced they will present P3 Myasthenia Gravis results on 2025-10-29 for Efgartigimod More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982924838986225) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2800 followers, XXX engagements


"$AGIO FDA extended PDUFA goal date for Agios Pharmaceuticals' drug Pyrukynd by X months to December X 2025. More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216555138719934) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:49Z 2789 followers, XXX engagements


"Kezar considers strategic options after FDA clash implements cost cuts and layoffs aiming to preserve value amid regulatory pressure"  
[X Link](https://x.com/OzmosiHealth/status/1979177249237528692) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:26Z 2802 followers, XX engagements


"$INSM +1.54% today as CHMP Recommends EU Approval of BRINSUPRI (brensocatib) for the Treatment of Non-Cystic Fibrosis Bronchiectasis More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183780930658678) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2802 followers, XXX engagements


"$GALT Galectin Therapeutics Reports Financial Results for the Quarter Ended June XX 2025 and Provides Business Update"  
[X Link](https://x.com/OzmosiHealth/status/1956026282765898199) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-08-14T16:13Z 2799 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $INCY Incyte will present Phase X Prurigo Data for Ruxolitinib (JAK1 InhibitorJAK2 InhibitorSTAT Inhibitor - Small Molecule) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1967909432853200947) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-09-16T11:12Z 2799 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $SRPT Sarepta will present Phase X Muscular DystrophiesMuscular Dystrophy Duchenne Data for Delandistrogene moxeparvovec (Gene TherapyDMD - Gene Therapy) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1976606737718489393) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-10T11:12Z 2802 followers, 1364 engagements


"$ALGS +4.39% today as Aligos Therapeutics Receives USAN Council Approval for pevifoscorvir sodium as Nonproprietary Name for ALG-000184 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978820990701355463) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T13:51Z 2802 followers, XXX engagements


"$SPRO +0.18% today as Spero Therapeutics Announces Presentations on Tebipenem Hbr at IDWeek More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978115177359769777) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T15:06Z 2799 followers, XXX engagements


"$ABBV +1.15% today as AbbVie Completes Acquisition of Gilgamesh Pharmaceuticals' Bretisilocin More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183758356971710) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2802 followers, XXX engagements


"$SLS Sellas Life Sciences announced they will present Preclinical T-Cell Peripheral Lymphoma results on 2025-10-18 for Tambiciclib More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216535849058314) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:49Z 2789 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $ACAD Acadia will present Preclinical Essential Tremor Data for SAN-711 (GABRA3 Modulator - Small Molecule) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1975519573668704620) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-07T11:12Z 2789 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $PFE Pfizer will present Phase X Bladder CancerMuscle Cancer Data for Enfortumab vedotin (NECTIN4 Inhibitor - Antibody Drug Conjugate) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1979143453578838476) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T11:12Z 2802 followers, XXX engagements


"$AGIO +5.11% today as Avanzanite Bioscience's Partner Agios Announces Positive CHMP Opinion for PYRUKYND (mitapivat) for Adults with Thalassemia More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183723116482883) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2802 followers, XX engagements


"$OSTX -XXXX% today as OS Therapies Granted Final Type C Meeting by U.S. FDA and pre-MAA Meeting by U.K. MHRA for OST-HER2 in the Prevention or Delay of Recurrent Fully Resected Pulmonary Metastatic Osteosarcoma More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183746927493138) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2802 followers, XXX engagements


"$BOLT +8.85% today as Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1973487513575551439) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-01T20:37Z 2802 followers, XXX engagements


"$SMMT +1.05% today as Summit Therapeutics Announces Expansion of Ivonescimab Global Phase III Development Program with HARMONi-GI3 Study in 1L Colorectal Cancer More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183707937247668) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2802 followers, XXX engagements


"Pelage Pharmaceuticals raised $120M Series B to develop PP405 a regenerative hair-loss therapy"  
[X Link](https://x.com/OzmosiHealth/status/1978515356558766185) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-15T17:36Z 2800 followers, XXX engagements


"$RGNX +3.55% today as REGENXBIO Announces Completion of Enrollment in Pivotal Trials of Subretinal Surabgene Lomparvovec for Wet AMD More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1975196185175511355) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-06T13:47Z 2792 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $HCM HUTCHMED will present Phase X Non-Small-Cell Lung Cancer Data for Savolitinib (C-Met InhibitorTK Inhibitor - Small Molecule) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1978781073002905645) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T11:12Z 2800 followers, XXX engagements


"$SNY +0.10% today as Press Release: AlphaMedixTM (212Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase X study demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumors More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1975920655846568070) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-08T13:46Z 2798 followers, XXX engagements


"$NBIX +1.56% today as Neurocrine Biosciences Presents New KINECT X Post-Hoc Analysis Demonstrating Rapid and Sustained Therapeutic Efficacy of INGREZZA (valbenazine) XX mg Capsules More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183784164508082) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2802 followers, XXX engagements


"$LBRX +3.37% today as LB Pharmaceuticals to Present Three Posters at 38th ECNP Congress Highlighting Clinical Activity and Safety Profile of LB-102 in Schizophrenia Including Positive Effects on Cognition and Negative Symptoms More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1975196166628270582) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-06T13:47Z 2789 followers, XXX engagements


"$SNSE -XXXXX% today as Sensei Biotherapeutics Reports New Clinical Results Highlighting Durable Progression Free Survival Data for Solnerstotug in PD-(L)1 Resistant Tumors at the ESMO Congress 2025 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183711443628141) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2802 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $INSM Insmed will present Phase X Hypertension Pulmonary Data for Treprostinil (PGI2 Agonist - Small Molecule) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1972620471415054442) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-09-29T11:12Z 2802 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $HCM HUTCHMED will present Phase X Soft Tissue Cancer Data for Surufatinib (VEGFR1 AntagonistVEGFR2 InhibitorVEGFR3 AntagonistFGFR Antagonist - Small Molecule) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1978781072373788896) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T11:12Z 2802 followers, XXX engagements


"$BMEA Biomea Fusion presented Phase X Type X Diabetes results on 2025-10-06 for Icovamenib More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1975742097073328629) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-08T01:56Z 2789 followers, XXX engagements


"$ABSI +21.57% today as Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December XX 2025; Announces Accelerated Initiation of Phase 1/2a Trial More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978458187624747224) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-15T13:49Z 2793 followers, XXX engagements


"$ARTL Artelo Biosciences presented P2 Anorexia results on 2025-10-16 for ART27.13 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982932543926314) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2800 followers, XXX engagements


"$BMRN Biomarin presented Phase X Achondroplasia results on 2025-09-08 for Vosoritide More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1965510263928492045) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-09-09T20:18Z 2791 followers, XXX engagements


"$IMAB I-Mab Biopharma announced they will present P1 Gastrointestinal Cancer results on 2025-10-23 for Givastomig More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978597954693759212) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-15T23:04Z 2800 followers, XXX engagements


"$BCTX BriaCell announced they will present Phase X Breast Cancer results on 2025-10-20 for SV-BR-1-GM More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216476180897804) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:48Z 2789 followers, XXX engagements


"$CYTK PDUFA date: September XX 2025 for aficamten approval from FDA misrepresented by defendants in a securities class action lawsuit. More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1976016443884896757) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-08T20:06Z 2800 followers, XXX engagements


"$OMER +142.73% today as Novo Nordisk and Omeros announce asset purchase and license agreement for Omeros' clinical-stage MASP-3 inhibitor zaltenibart (OMS906) More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978458199893098928) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-15T13:49Z 2799 followers, XXX engagements


"$PMVP PMV Pharmaceuticals announced they will present Phase X Oncology Solid Tumor Unspecified results on 2025-10-24 for Rezatapopt More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216523845017966) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:49Z 2791 followers, XXX engagements


"$LEGN Legend Biotech Appoints Carlos Santos as Chief Financial Officer"  
[X Link](https://x.com/OzmosiHealth/status/1957544501288812697) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-08-18T20:45Z 2802 followers, XXX engagements


"$ABSI AbSci announced they will present P1 Alopecia Areata results in 2H26 for ABS-201 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982913505927386) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2802 followers, XXX engagements


"$OSE as OSE Immunotherapeutics and the FoRT Foundation Announce Completion of Enrollment in Combi-TED a Phase X Clinical Trial Evaluating Tedopi in Combination with Nivolumab or Docetaxel in Patients with Non-Small Cell Cancer More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1966235481605042221) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-09-11T20:20Z 2802 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $MRK Merck will present Phase X HIV Infections Data for Doravirine (NNRT Inhibitor - Small Molecule) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1978418677822484896) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-15T11:12Z 2802 followers, XXX engagements


"$BLTE +1.08% today as Belite Bio Announces China NMPA Agrees to New Drug Application with Priority Review based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978458195543597446) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-15T13:49Z 2792 followers, XXX engagements


"$LIXT -XXXX% today as LIXTE Biotechnology Holdings Highlights Q4 2025 Priorities Including Ongoing Advancement of Lead Candidate LB-100 Strategic Oncology Business Development and Acquisition Plans More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978821012515905636) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T13:51Z 2802 followers, XXX engagements


"$MRK Merck presented P3 HIV Infections results on 2025-10-15 for Doravirine More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982947051933908) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2797 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $PFE Pfizer will present Phase X Cachexia Data for Ponsegromab (GDF15 Inhibitor - Antibody) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1978781071811731689) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T11:12Z 2802 followers, XXX engagements


"$AZN +0.47% today as IMFINZI (durvalumab) regimen reduced the risk of disease recurrence or death by XX% in high-risk non-muscle-invasive bladder cancer in the POTOMAC Phase III trial More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183718938837337) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2802 followers, XX engagements


"$ZYME Zymeworks announced they will present Phase X Oncology Solid Tumor Unspecified results on 2025-10-23 for ZW-191 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216551800054108) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:49Z 2790 followers, XXX engagements


"$GILD Gilead Sciences announced they will present Phase X Esophageal CancerGastrointestinal Cancer results on 2025-10-18 for Domvanalimab More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216507248193570) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:49Z 2789 followers, XXX engagements


"$ELDN +2.81% today as Eledon Pharmaceuticals to Present Results from Phase X BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology Kidney Week 2025 Annual Meeting More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183726903845232) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2802 followers, XXX engagements


"$MIRA +63.64% today as MIRA Pharmaceuticals Announces Oral Mira-55 Outperformed Injected Morphine in Normalizing Pain and Reducing Inflammation Supporting Its Planned IND for Chronic Inflammatory Pain More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978820982543405434) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T13:51Z 2802 followers, XXX engagements


"Ahead of its first clinical readout Tubulis raises 308M to fuel its ADC (antibody-drug conjugate) ambitions"  
[X Link](https://x.com/OzmosiHealth/status/1978515358857204092) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-15T17:36Z 2802 followers, XXX engagements


"$GALT Galectin announced they will present Phase X Non-alcoholic Steatohepatitis results on 2025-11-10 for Belapectin More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1976016406199058687) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-08T20:06Z 2800 followers, XXX engagements


"$IRON +23.72% today as Disc Medicine to Present Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2025 American Society of Nephrology (ASN) Kidney Week More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183788321026470) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2802 followers, XXX engagements


"$APS as Aptose's Tuspetinib Exceeds Expectations When Combined with Standard of Care Treatment Across Diverse Populations of Newly Diagnosed AML More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978821003905032309) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T13:51Z 2802 followers, XXX engagements


"$EVAX Evaxion Biotech announced they will present Phase X Melanoma results on 2025-10-17 for EVX-01 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216503305531640) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:49Z 2790 followers, XXX engagements


"$ANL Adlai Nortye announced they will present Preclinical Oncology Solid Tumor Unspecified results on 2025-10-25 for AN-4035 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216467138068634) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:48Z 2789 followers, XX engagements


"$SMMT Summit announced they will present P3 Non-Small-Cell Lung Cancer results on 2025-10-19 for Ivonescimab More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982921441566901) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2800 followers, XXX engagements


"$ACET Adicet Bio dosed the first Systemic Sclerosis patient in Phase X trial of ADI-001 for Autoimmune Diseases. More Info: $XBI $IBB $XPH $PPH"  
[X Link](https://x.com/OzmosiHealth/status/1948338030974226558) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-07-24T11:02Z 2800 followers, XXX engagements


"$CYTK PDUFA Summary: FDA extended action date for Aficamten NDA to December XX 2025. Stock price fell on disclosure. More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216565318337012) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:49Z 2798 followers, XXX engagements


"$CLLS +9.20% today as Cellectis' R&D Day Highlights Lasme-cel's Potential to Address Significant Unmet Need for Patients with r/r B-ALL More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982869843190122) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2802 followers, XXX engagements


"$ONC +2.86% today as BeOne Medicines' Sonrotoclax Granted Breakthrough Therapy Designation by U.S. FDA More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1977752758724739311) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-13T15:06Z 2802 followers, XXX engagements


"$ACET Adicet Bio presented Phase X Autoimmune Disease Unspecified results on 2025-10-07 for Prulacabtagene leucel More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1976016429926248703) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-08T20:06Z 2800 followers, XXX engagements


"$LYRA Lyra Therapeutics announced they will present Phase X Sinusitis results on 2025-10-13 for Mometasone furoate More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1975742079666889189) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-08T01:56Z 2791 followers, XXX engagements


"$BMY Bristol-Myers Squibb announced they will present Phase X Non-Small-Cell Lung Cancer results on 2025-10-17 for Izalontamab brengitecan More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216480001994888) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:48Z 2791 followers, XXX engagements


"$RARE Ultragenyx presented Phase X Glycogen Storage Disease Type Ia results on 2025-09-08 for Pariglasgene brecaparvovec More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1965510301836550471) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-09-09T20:19Z 2802 followers, XXX engagements


"$NXTC +3.93% today as NextCure and Simcere Zaiming Announce Expansion of Ongoing Phase X Trial of SIM0505 (CDH6 ADC) into the United States More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978821016164962550) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T13:51Z 2802 followers, XXX engagements


"$REGN +0.97% today as Libtayo (cemiplimab) Recommended for EU Approval by the CHMP for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma (CSCC) with a High Risk of Recurrence After Surgery and Radiation More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183734944366997) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2802 followers, XXX engagements


"$PYXS Pyxis Oncology announced they will present Phase X Oncology Solid Tumor Unspecified results on 2025-10-18 for Micvotabart pelidotin More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216528064467421) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:49Z 2789 followers, XXX engagements


"$MNPR Monopar Therapeutics announced they will present P2 Hepatolenticular Degeneration results on 2025-11-09 for Tiomolibdic acid More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982917486342508) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2798 followers, XXX engagements


"$TOVX Theriva Biologics announced they will present Phase X Pancreatic Cancer results on 2025-10-20 for Zabilugene almadenorepvec More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216540047622604) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:49Z 2790 followers, XXX engagements


"$IMAB +1.64% today as I-Mab to Present Short-Talk on Updated Givastomig Monotherapy Data at the 2025 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978115152986714261) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T15:06Z 2802 followers, XXX engagements


"$NUVL Nuvalent announced they will present Preclinical Oncology Solid Tumor Unspecified results on 2025-10-24 for NVL-330 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216519747187123) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:49Z 2789 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $ALPMY Astellas Pharma will present Phase X Bladder CancerMuscle Cancer Data for Enfortumab vedotin (NECTIN4 Inhibitor - Antibody Drug Conjugate) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1979143454992273713) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T11:12Z 2802 followers, XXX engagements


"$ATAI -XXXX% today as atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003 Underscoring its Potential in Treatment-Resistant Depression More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982877569114112) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2800 followers, XXX engagements


"$GYRE -XXXX% today as Gyre Therapeutics to Present Results from Positive Phase X Clinical Trial Evaluating Hydronidone for the Treatment of Liver Fibrosis in Chronic Hepatitis B at AASLDThe Liver Meeting 2025 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978115145185292742) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T15:06Z 2790 followers, XXX engagements


"Candel secures a $XXX M loan (with $XX M upfront) to launch Phase III testing of its immunotherapy CAN-2409 in NSCLC"  
[X Link](https://x.com/OzmosiHealth/status/1978515359683477968) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-15T17:36Z 2800 followers, XXX engagements


"$PHGE +4.94% today as BiomX Provides a Program Update and Announces New FDA Feedback Potentially Expanding BX004 Development Pathways More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183769987760560) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2802 followers, XXX engagements


"$MRK Merck presented P3 HIV Infections results on 2025-10-15 for Islatravir More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982950545887710) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2799 followers, XXX engagements


"TrumpRx brings Merck KGaA onboard its voucher program as one of nine recipients accelerating review of IVF therapy Pergoveris"  
[X Link](https://x.com/OzmosiHealth/status/1979177248394490052) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:26Z 2802 followers, XXX engagements


"$ZLAB +3.61% today as Zai Lab Announces Oral Presentation of Updated Data from Global Phase X Trial of Zocilurtatug Pelitecan (ZL-1310) a Potential First-in-Class DLL3-Targeted ADC at 2025 AACR-NCI-EORTC Conference More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1977830362504974601) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-13T20:14Z 2800 followers, XXX engagements


"$NGNE +11.06% today as Neurogene Announces Positive Regulatory Update for NGN-401 Gene Therapy in Rett Syndrome with Plans to Initiate Dosing in Embolden Registrational Trial in Q4 2025 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1976281356079374497) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-09T13:39Z 2789 followers, XXX engagements


"$AZN +0.47% today as IMFINZI (durvalumab)-based regimen reduced the risk of death by XX% in early gastric cancer vs. chemotherapy alone in MATTERHORN Phase III trial More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183715235311835) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2802 followers, XX engagements


"$VRTX +0.99% today as Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183742896795862) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2802 followers, XX engagements


"$ZNTL Zentalis Pharmaceuticals announced they will present Phase X Oncology Solid Tumor UnspecifiedGastrointestinal Cancer results on 2025-10-24 for Azenosertib More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216547890971001) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:49Z 2790 followers, XXX engagements


"$XNCR -XXXXX% today as Xencor Announces Presentation of Initial Phase X Dose-Escalation Results of XmAb819 in Clear Cell Renal Cell Carcinoma at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978213496346067120) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:37Z 2790 followers, XXX engagements


"$ABVX Abivax presented Phase X Colitis Ulcerative results on 2025-10-06 for Obefazimod More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1975742090400182319) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-08T01:56Z 2800 followers, XXX engagements


"$KNSA -XXXX% today as Kiniksa Pharmaceuticals Announces U.S. Orphan Drug Designation for KPL-387 for the Treatment of Pericarditis More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183750706545083) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2802 followers, XXX engagements


"$IMAB I-Mab finishes enrolling patients in Phase 1b study for Givastomig with immunochemotherapy in 1L gastric cancer. More Info: $XBI $IBB $XPH $PPH"  
[X Link](https://x.com/OzmosiHealth/status/1954868584037102063) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-08-11T11:32Z 2791 followers, XXX engagements


"$CORT +1.40% today as Corcept Submits Marketing Authorization Application to European Medicines Agency for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978115181445104006) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T15:06Z 2790 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $MRK Merck will present Phase X HIV Infections Data for Islatravir (NRT Inhibitor - Small Molecule) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1978418677235232938) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-15T11:12Z 2802 followers, XXX engagements


"$KYMR +2.76% today as Kymera Therapeutics Announces Late-Breaking Oral Presentations on KT-621 a First-In-Class Oral STAT6 Degrader at the European Academy of Dermatology & Venereology and European Respiratory Society Congresses More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1968315944582701436) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-09-17T14:07Z 2800 followers, XXX engagements


"$CSLLY as CSL Behring Signs Letter of Intent with pan-Canadian Pharmaceutical Alliance (pCPA) for Public Reimbursement of HEMGENIX (etranacogene dezaparvovec) the First Gene Therapy for Hemophilia B More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1975196189227196468) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-06T13:47Z 2800 followers, XXX engagements


"Sanofi will explore using EVOQs platform to craft autoimmune therapies aimed at restoring immune balance"  
[X Link](https://x.com/OzmosiHealth/status/1978828028076601523) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T14:19Z 2802 followers, XXX engagements


"$JNJ Johnson & Johnson presented Phase X Depressive Disorder Major results on 2025-10-12 for Lumateperone More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1977833538520039576) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-13T20:27Z 2802 followers, XXX engagements


"$GILD Gilead Sciences presented P2 HIV Infections results on 2025-10-15 for Teropavimab More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982940295000348) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2798 followers, XXX engagements


"Novartis advances Fabhalta (iptacopan) toward full FDA approval in IgA nephropathy (IgAN) preparing a submission next year"  
[X Link](https://x.com/OzmosiHealth/status/1978828030463091145) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T14:19Z 2802 followers, XXX engagements


"$IMAB -XXXX% today as I-Mab Announces Acceleration of Givastomig Investment and Leadership Appointments More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1965048374635229371) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-09-08T13:43Z 2791 followers, XXX engagements


"$ENVB +15.46% today as Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to Bretisilocin Recently Acquired by AbbVie in $XXX Billion Deal More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978458191911321919) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-15T13:49Z 2802 followers, XXX engagements


"$CADL Candel Therapeutics announced they will present Phase X Prostate Cancer results on 2025-11-07 for Aglatimagene besadenovec More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1975291011816431880) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-06T20:04Z 2800 followers, XXX engagements


"$PCVX +1.76% today as Vaxcyte Advances VAX-31 Infant Phase X Dose-Finding Study with First Participants Receiving VAX-31 Optimized Dose More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1963247069398761771) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-09-03T14:25Z 2791 followers, XXX engagements


"$AKRO Akero announced they will present Phase X Non-alcoholic Steatohepatitis results on 2025-11-09 for Efruxifermin More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1976016388608110859) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-08T20:06Z 2789 followers, XXX engagements


"$VOR -XXXX% today as Vor Bio Announces Publication of China Phase X Study of Telitacicept in Systemic Lupus Erythematosus in The New England Journal of Medicine More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978821008250310898) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T13:51Z 2802 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $KURA Kura Oncology will present Preclinical Oncology Solid Tumor Unspecified Data for Darlifarnib (FT Inhibitor - Small Molecule) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1978781071153242458) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T11:12Z 2802 followers, XXX engagements


"$LXRX +1.39% today as Lexicon Pharmaceuticals Presents Additional Pilavapadin Data in Diabetic Peripheral Neuropathic Pain at 19th Annual Pain Therapeutics Summit More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978115173442265120) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T15:06Z 2791 followers, XXX engagements


"$BMEA Biomea Fusion announced they will present Phase X Healthy Volunteers results in 1H26 for BMF-650 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1975742067159527902) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-08T01:56Z 2789 followers, XXX engagements


"$EVAX -XXXXX% today as Evaxion reports XX% Objective Response Rate in phase X trial with AI-designed personalized cancer vaccine EVX-01 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183765873144032) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2802 followers, XXX engagements


"$CYBN Cybin announced they will present Phase X Generalized anxiety disorder results in 1Q26 for CYB-004 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1970944302999060695) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-09-24T20:11Z 2800 followers, XXX engagements


"$SXTP -XXXX% today as XX Degrees Pharmaceuticals Announces No Detection of Babesia Infection in First Patient Following Treatment with Tafenoquine in Relapsing Babesiosis Study More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978458203575685424) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-15T13:49Z 2797 followers, XXX engagements


"$TNXP -XXXX% today as Tonix Pharmaceuticals Presented Data on TNX-801 Mpox Vaccine at World Vaccine CongressEurope 2025 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183731496583412) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2802 followers, XXX engagements


"$ACET +3.13% today as Adicet Bio Announces First Patient Dosed in Phase X Clinical Trial of ADI-001 in Treatment-Refractory Rheumatoid Arthritis (RA) More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978820998859231488) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T13:51Z 2802 followers, XXX engagements


"$GILD Gilead Sciences presented P2 HIV Infections results on 2025-10-15 for Zinlirvimab More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982943717519679) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2798 followers, XXX engagements


"$AUPH +0.93% today as Aurinia Announces Upcoming Presentations of New Data on LUPKYNIS at American College of Rheumatology Convergence and American Society of Nephrology Kidney Week 2025 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978458211301683405) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-15T13:49Z 2802 followers, XXX engagements


"$CRBP +0.28% today as Corbus Pharmaceuticals to Present CRB-701 Phase 1/2 Data at ESMO 2025 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978115213036601782) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T15:06Z 2791 followers, XXX engagements


"$JNJ Johnson & Johnson presented Phase X Colitis Ulcerative results on 2025-10-07 for Guselkumab More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1976016440537837718) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-08T20:06Z 2802 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $INCY Incyte will present Phase X Hidradenitis Suppurativa Data for Povorcitinib (JAK1 Inhibitor - Small Molecule) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1967909432156885172) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-09-16T11:12Z 2800 followers, XXX engagements


"$INCY +1.20% today as Incyte Announces New 24-Week Phase X Data from the STOP-HS Clinical Trial Program of Povorcitinib in Hidradenitis Suppurativa at EADV 2025 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1968315936479302065) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-09-17T14:07Z 2799 followers, XXX engagements